Life Sciences Deskbook
Emerging Business Tools
Morgan Lewis placed highly among global law firms in BioPharm Insight’s second quarter licensing and mergers and acquisitions rankings.
In 2009, Morgan Lewis placed highly among global law firms in BioPharm Insight’s annual rankings of the year’s licensing and mergers and acquisitions activity.
Jan 18, 2010 - The Life Sciences Industry: Trends and Predictions, PLC Life Sciences Cross-Border Handbook
Steve Mahinka is interviewed for a special feature on the future of the life sciences industry.
The FTC has voted unanimously to approve Pfizer's acquisition of Wyeth.
Morgan Lewis represented LEO Pharma in the $1 billion acquisition of exclusive product licensing rights and inventories from LEO Pharma by Warner Chilcott plc.
Morgan Lewis Business and Finance partner Stephen Jannetta is appointed to the Pennsylvania Bio board of directors.
Following the addition earlier this month of six healthcare partners on the East and West Coasts, Morgan Lewis today announced another seven attorneys have joined the firm, doubling the size of its FDA & Healthcare Practice.
Solidifying its position as a full-service legal resource for the life sciences industry, Morgan Lewis today announced the addition of six healthcare partners to its FDA/Healthcare Regulation Practice.
Morgan Lewis is pleased to announce the launch of the second edition of the Emerging Life Sciences Companies Deskbook.
Apr 15, 2008 - Life Sciences Advisers: The 2008 Elite, PLCCross-border Quarterly
Morgan Lewis ranked in PLCCross-border Quarterly 2008 Life Sciences Legal Market Review.
Morgan Lewis today announced the addition of Thomas E. Duley—formerly the head of the transactional legal group at PDL BioPharma, Inc.—as of counsel, resident in the firm’s San Francisco office.
Dec 31, 2007 - The Threat of the New, Scrip 100
Natalie Kingston is quoted on the future of the CRO industry.
141 Morgan Lewis lawyers have been recognized in The Best Lawyers in America 2008.
Morgan Lewis is pleased to announce that William Jackson (Jack) Matney, Jr. and Robert W. (Bob) Busby have joined the firm as partners in the Washington, D.C. office. Mr. Matney and Mr. Busby focus on patent litigation and related patent services.
Morgan Lewis is pleased to announce that Andrew Ruskin has brought his healthcare regulatory practice to the firm. Mr. Ruskin counsels clients on the full array of regulatory issues affecting the healthcare industry.
Morgan Lewis is pleased to announce that the Life Sciences Interdisciplinary Practice and several of its attorneys are recognized in the PLCCross-border Life Sciences Handbook 2006/07.
Morgan Lewis attorneys represented the Carnegie Institution of Washington before the U.S. Patent & Trademark Office in obtaining U.S. Patent 6,506,559, which claims the subject matter awarded the Nobel Prize in Medicine for 2006.
Morgan Lewis is pleased to announce the addition of five partners and five associates to its global Intellectual Property Practice as of December 1.
On August 2, 2006, United States District Judge William Bassler entered a judgment on behalf of Morgan Lewis clients Daiichi Pharmaceutical Co., Ltd. and Daiichi Sankyo Inc.
On June 22, 2006 the Intellectual Property (IP) Law Section of the American Bar Association (ABA) held its summer meeting in Boston. Resolution 413-1, entitled State Prescription Drug Compulsory Licensing was presented, debated, and overwhelmingly passed.
Morgan Lewis sponsors BIO 2006, the world's largest gathering of biotechnology leaders.
Morgan Lewis is pleased to announce that Practical Law Company recommends the firm’s Life Sciences Practice and its attorneys in the PLCCross-border Life Sciences Handbook 2005/06.
Morgan Lewis & Bockius LLP, a global law firm, today announced a new joint venture with TMI Associates, one of the top law firms in Japan, effective immediately. The new partnership, named Morgan Lewis-TMI, will focus primarily on cross-border corpora